Literature DB >> 31148443

Red Blood Cells-Derived Vesicles for Delivery of Lipophilic Drug Camptothecin.

Sahil Malhotra, Shweta Dumoga, Parul Sirohi, Neetu Singh1.   

Abstract

Recently, cell membrane-derived nanoparticles, particularly of RBCs, have been explored for delivery of hydrophilic solutes of varied size and complexities. So far, these naturally derived nanoparticles show a significant overlap with liposomes in terms of stability, solute encapsulation, and release. Unlike hydrophilic molecules, which are loaded inside the aqueous core, hydrophobic moieties largely partition inside the lipophilic shell, hence fate of these nanocarriers may be different. Since vesicles have more complex membrane architecture (due to natural lipids and additional proteins and glycoproteins), ease of loading hydrophobic drug, its release pattern, and overall particle stability cannot be compared to those of synthetic lipid-based carriers. Therefore, we derived nanovesicles (NVEs) from RBC membrane, loaded with hydrophobic drug camptothecin (CPT) and labeled noncovalently with amphiphilic fluorophore (CM-DiI). Although both CPT and CM-DiI are known to partition inside the membrane, the overall stability of NVEs and composition of membrane proteins, particularly CD47, "marker of self", did not change. Additionally, the developed NVEs were found to be nonphagocytic even in the presence of serum and showed minimal stimulation of macrophages to release cytokines. Further, this system showed slow release but strong retention of CPT and CM-DiI, respectively, over 24 h, hence appropriate for theranostic applications. Also, NVEs were internalized by lung carcinoma cells and possessed slightly higher toxicity than free CPT. When injected intravenously in balb/c mice, these nanovesicles showed higher retention in blood over 48 h and insignificant accumulation in vital organs like heart and kidneys, thus suggesting its potential for in vivo application. We believe that this system has superior stealth and comparable physicochemical properties to synthetic lipid-based nanocarriers; hence, it can be further developed as personalized medicine.

Entities:  

Keywords:  CM-DiI; RBC-derived nanovesicles; camptothecin; lung carcinoma; theranostic

Mesh:

Substances:

Year:  2019        PMID: 31148443     DOI: 10.1021/acsami.9b04827

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  11 in total

Review 1.  Red Blood Cell Inspired Strategies for Drug Delivery: Emerging Concepts and New Advances.

Authors:  Endong Zhang; Philana Phan; Hanan Ahmed Algarni; Zongmin Zhao
Journal:  Pharm Res       Date:  2022-07-07       Impact factor: 4.200

Review 2.  Different Sourced Extracellular Vesicles and Their Potential Applications in Clinical Treatments.

Authors:  Leila Bahmani; Mujib Ullah
Journal:  Cells       Date:  2022-06-21       Impact factor: 7.666

Review 3.  Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment.

Authors:  Kasturee Chakraborty; Archana Tripathi; Sukumar Mishra; Argha Mario Mallick; Rituparna Sinha Roy
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

Review 4.  Recent Progress in Red Blood Cells-Derived Particles as Novel Bioinspired Drug Delivery Systems: Challenges and Strategies for Clinical Translation.

Authors:  Antony Vincy; Sarmistha Mazumder; Indranil Banerjee; Kuo Chu Hwang; Raviraj Vankayala
Journal:  Front Chem       Date:  2022-04-27       Impact factor: 5.545

Review 5.  Roles and Applications of Red Blood Cell-Derived Extracellular Vesicles in Health and Diseases.

Authors:  Lan Yang; Shiqi Huang; Zhirong Zhang; Zhenmi Liu; Ling Zhang
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

Review 6.  Strategies to Enhance Extracellular Vesicle Production.

Authors:  Juhee Hahm; Jonghoon Kim; Jongmin Park
Journal:  Tissue Eng Regen Med       Date:  2021-07-18       Impact factor: 4.451

Review 7.  Extracellular Vesicles from Red Blood Cells and Their Evolving Roles in Health, Coagulopathy and Therapy.

Authors:  Kiruphagaran Thangaraju; Sabari Nath Neerukonda; Upendra Katneni; Paul W Buehler
Journal:  Int J Mol Sci       Date:  2020-12-25       Impact factor: 5.923

8.  NIR triggered PLGA coated Au-TiO2 core loaded CPT-11 nanoparticles for human papillary thyroid carcinoma therapy.

Authors:  Tianyu Yu; Lingling Tong; Yu Ao; Genmao Zhang; Yunpeng Liu; Hejia Zhang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 9.  Chronicles of Nanoerythrosomes: An Erythrocyte-Based Biomimetic Smart Drug Delivery System as a Therapeutic and Diagnostic Tool in Cancer Therapy.

Authors:  Shamama Javed; Sultan Alshehri; Ambreen Shoaib; Waquar Ahsan; Muhammad Hadi Sultan; Saad Saeed Alqahtani; Mohsin Kazi; Faiyaz Shakeel
Journal:  Pharmaceutics       Date:  2021-03-10       Impact factor: 6.321

Review 10.  Current and Future Prospective of Injectable Hydrogels-Design Challenges and Limitations.

Authors:  Saud Almawash; Shaaban K Osman; Gulam Mustafa; Mohamed A El Hamd
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.